Standard Biotools (LAB) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Interest Coverage Ratio Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.64% |
| Mar 31, 2026 | 33.35% |
| Dec 31, 2025 | -132.63% |
| Sep 30, 2025 | -740.44% |
| Jun 30, 2025 | -567.42% |
| Mar 31, 2025 | -72.73% |
| Dec 31, 2024 | -18.96% |
| Sep 30, 2024 | 43.21% |
| Jun 30, 2024 | -14.24% |
| Mar 31, 2024 | 25.48% |
| Dec 31, 2023 | -26.71% |
| Sep 30, 2023 | -68.41% |
| Jun 30, 2023 | -66.06% |
| Mar 31, 2023 | -83.50% |
| Dec 31, 2022 | -51.62% |
| Sep 30, 2022 | -20.44% |
| Jun 30, 2022 | -89.11% |
| Mar 31, 2022 | -71.40% |
| Sep 30, 2021 | -110.31% |
| Jun 30, 2021 | -69.13% |